See the presentation that convinced investors like CapitalG to back a new kind of kidney care startup

Hello,

Welcome to Insider Healthcare. I’m Lydia Ramsey Pflanzer, and today in healthcare news:


If you’re new to this newsletter, sign up here. Comments, tips, recipes? Email me at [email protected] or tweet @lydiaramsey125. Now, let’s get to it…


Dialysis machine
A nurse prepares a dialysis machine. Radu Sigheti/Reuters

Alphabet’s VC arm just sank $US140 ($181) million into a startup that wants to unseat dialysis giants like DaVita. We got the pitch deck that convinced CapitalG to back Strive Health.

  • Strive Health raised $US140 ($181) million in Series B funding on Tuesday. Alphabet’s CapitalG led the round.
  • The startup works with insurers and health systems on a new way to care for people with mid- and late-stage kidney disease.

See the presentation that won over investors >>


Anne Wojcicki 23andme
23andMe cofounder Anne Wojcicki. Kimberly White / Getty Images

How 5 top DNA-testing companies like 23andMe and Color are shaping the next chapter of the genetics industry

Find out how top players are navigating the industry’s future>>


Moderna vaccine
Biotechnology company Moderna protocol files for COVID-19 vaccinations are kept at the Research Centers of America in Hollywood, Florida, on August 13, 2020. Photo by CHANDAN KHANNA/AFP via Getty Images

Moderna begins testing its COVID-19 vaccine in babies and young children

Read on about the trial just getting underway>>


More stories we’re reading today:


– Lydia